Vascular ultrasound in the monitoring of vascular injury in patients after intravenous chemotherapy | [Pakistan Journal of Pharmaceutical Sciences • 2025]

Author(s):

1. Liling Lin: Department of Ultrasound, West China Xiamen Hospital of Sichuan University,Xiamen, Fujian,China

2. Ling Li: Department of Ultrasound, Zhangzhou Municipal Hospital of Fujian Province,Zhangzhou, Fujian,China

3. Jinglian Lin: Department of Imaging, Zhangzhou Municipal Hospital of Fujian Province,Zhangzhou, Fujian,China

Abstract:

This study investigated vascular injury incidence, symptoms, and changes in vascular wall thickness and blood flow in 140 chemotherapy patients. Vascular ultrasound and laboratory tests were conducted at 1 week, 1 month, and 3 months post-chemotherapy. Results showed that vascular injury incidence increased over time (12.9% at 1 week, 25.0% at 1 month, 34.3% at 3 months, P<0.05). Vascular wall thickness (IMT) thickened from 0.61±0.11 mm at baseline to 0.85±0.22 mm at 3 months (P<0.01) and vascular diameter increased from 2.34±0.22 mm to 2.55±0.33 mm at 3 months (P<0.01). Severe phlebitis incidence rose from 2.9% at 1 week to 7.1% at 3 months (P<0.01). Elevated CRP and D-dimer levels correlated with increased vascular wall thickness and thrombosis. Enhanced monitoring and personalized interventions are needed to reduce complications. Combining ultrasound and laboratory markers can improve assessment of chemotherapy-induced vascular injury.

Page(s): 1435-1441

DOI: 10.36721/PJPS.2025.38.4.REG.13883.1

Published: Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Keywords:

Chemotherapy , inflammation , Vascular injury , Phlebitis , venous access devices , abnormal blood flow , thrombotic markers , vascular wall thickness

References:

[1] Anastasiou M,Oikonomou E,Theofilis P,Kaski JC .2023 .Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients. Vasc Pharmacol, 152 : 107195.

[2] Angjelova A,Jovanova E,Polizzi A,Pavlovic A .2024 .Impact of periodontitis on endothelial risk dysfunction and oxidative stress improvement in patients with cardiovascular disease. J Clin Med, 13(13) : 3781.

[3] Aryal S,Park S,Park H,Kim J,Lee K .2023 .Clinical trials for oral, inhaled and intravenous drug delivery systems for lung cancer and emerging nanomedicinebased approaches. Int J Nanomedicine., 18 : 7865-7888.

[4] Dent SF,Kikuchi R,Kondapalli L,Dent R .2020 .Optimizing cardiovascular health in patients with cancer: A practical review of risk assessment, monitoring, and prevention of cancer treatment-related cardiovascular toxicity. Am Soc Clin Oncol Educ Book, 40 : 501-515.

[5] Gao C,Xu D,Sun C .2021 .Application of musculoskeletal ultrasound in real-time dynamic detection of Luschka joint hyperplasia of cervical vertebrae. J Med, 11(2) : 321-331.

[6] Khanna AK,Khanna D AK .2023 .Uncommon ulcers of the extremities. , : 363-376.

[7] Kumar V,Vellapandian C .2024 .Unraveling the nexus between ambient air pollutants and cardiovascular morbidity: Mechanistic insights and therapeutic horizons. , 16(9) : e68650.

[8] Lopez-Garzon M,Cantarero-Villanueva I,LegerenAlvarez M,Fernandez-Lopez C .2022 .Prevention of chemotherapy-induced peripheral neuropathy with PRESIONA, a therapeutic exercise and blood flow restriction program: A randomized controlled study protocol. Phys Ther, 102(3) : pzab282.

[9] Lustberg MB,Kuderer NM,Desai A,Lyman GH,Kushi LH .2023 .Mitigating long-term and delayed adverse events associated with cancer treatment: Implications for survivorship. Nat Rev Clin Oncol., 20(8) : 527-542.

[10] McLaughlin M,Florida-James G,Ross M .2021 .Breast cancer chemotherapy vascular toxicity: A review of mediating mechanisms and exercise as a potential therapeutic. Vasc Biol, 3(1) : R106-R120.

[11] Qu X,Zhou D,Lu J,Wang Y,Li Z Y .2023 .Cancer nanomedicine in preoperative therapeutics: nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy and phototherapy. , 24 : 136-152.

[12] Saketkoo LA,Frech T,Varju C,Csikos G C .2021 .A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. Best Pract. Res. Clin. Rheumatol, 35(3) : 101707.

[13] Stephenson E,McLaughlin M,Bray JW,Ross M .2024 .Nutrition modulation of cardiotoxicity in breast cancer: A scoping review. Nutrients., 16(21) : 3777.

[14] Terwoord JD,Beyer AM,Gutterman DD .2022 .Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther, 237 : 108116.

[15] Tiwari A,Elgrably B,Saar G,Bhatia R G .2022 .Multiscale imaging of vascular pathologies in cardiovascular disease. Front Med, 8 : 754369.

[16] Wei G,Wang Y,Yang G,Li H,Zhang J .2021 .Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics., 11(13) : 6370-6391.

[17] Wong ND,Budoff MJ,Ferdinand K,Blaha MJ K .2022 .Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement. Am. J. Prev. Cardiol., 10 : 100335.

[18] Xu Y,Qi Y,Lu Z,Zhang L,Wang H L .2024 .Navigating precision: the crucial role of next-generation sequencing recurrence-risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer. Cancer Biol Ther., 25(1) : 2405060.

[19] Yang Y,Zhang X,Zhang R,Li H,Wang X .2024 .Current status and progress in arterial stiffness evaluation: A comprehensive review. Adv. Ultrasound Diagn. Ther., 8(4) : 172-182.

[20] Zeng ZM,Mo N,Zeng J,Li H,Wang X .2022 .Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol., 14(9) : 1604-1612.

[21] Zhang T,Liu N,Xu J,Wang Y,Li H Y .2023 .Flexible electronics for cardiovascular healthcare monitoring. Innovation., 4(5) : 100458.

Citations

Downloads

Views